Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • casey6r0wn
    Junior Member
    • Feb 2013
    • 2

    Nextera-Truseq hybrid library prep

    First, many thanks to ECO et al for this thread.

    I have a related question.

    Is it possible to sequence a library that has a one Truseq end and one Nextera end?

    For example:

    5'-CommonEnd-Index1-InnerNextera-N^n-InnerTruseq-Index2-CommonEnd-3'

    Thanks for you thoughts.
  • pmiguel
    Senior Member
    • Aug 2008
    • 2328

    #2
    Originally posted by casey6r0wn View Post
    First, many thanks to ECO et al for this thread.

    I have a related question.

    Is it possible to sequence a library that has a one Truseq end and one Nextera end?

    For example:

    5'-CommonEnd-Index1-InnerNextera-N^n-InnerTruseq-Index2-CommonEnd-3'

    Thanks for you thoughts.
    Presuming you are running the samples on a MiSeq, I think it could work. Devil is in the details, of course...

    --
    Phillip

    Comment

    • casey6r0wn
      Junior Member
      • Feb 2013
      • 2

      #3
      Are you implying that it would not work on a HiSeq, but will on a MiSeq? How will it matter in this context? Thanks for the clarification.

      Assuming a library has the correct terminal oligos (for annealing to the flow cell) and one uses the right mix of sequencing primers...

      Comment

      • pmiguel
        Senior Member
        • Aug 2008
        • 2328

        #4
        Originally posted by casey6r0wn View Post
        Are you implying that it would not work on a HiSeq, but will on a MiSeq? How will it matter in this context? Thanks for the clarification.

        Assuming a library has the correct terminal oligos (for annealing to the flow cell) and one uses the right mix of sequencing primers...
        The MiSeq comes loaded with all the primers needed to sequence both Nextera and TruSeq libraries as well as dual indexes.

        The HiSeq requires extra reagents, both primers and SBS reagents to deal with the extra index cycles. At least in "high output mode".

        In Rapid mode, I think the situation is similar to that for the MiSeq.

        I forgot to note that you still have to set up the sample sheet right for the MiSeq. To get dual indexes to work you have to choose "Amplicon" as your recipe, you get an error if you try to choose "Default". Also, you need to input the index sequences for your i7 and i5 reads.

        --
        Phillip

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        16 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        17 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        37 views
        0 reactions
        Last Post SEQadmin2  
        Working...